NCT00663845View on ClinicalTrials.gov

Assessing Efficacy and Safety of Flexible Dosing With Vardenafil in Subjects With Erectile Dysfunction and Hyperlipidemia

PHASE4CompletedINTERVENTIONAL
Enrollment

395

Participants

Timeline

Start Date

May 31, 2006

Study Completion Date

April 30, 2007

Conditions
Erectile Dysfunction
Interventions
DRUG

Levitra (Vardenafil, BAY38-9456)

10mg Vardenafil taken orally 1h prior to sexual intercourse

DRUG

Placebo

Matching placebo

Sponsors

Lead Sponsor

Bayer

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Bayer

INDUSTRY